Despite the limitations of its current data collection systems, the Drug Enforcement Administration could do more to identify patterns that indicate possible diversion within the U.S. drug supply chain, the Government Accountability Office said in a report to Congress. The January 2020 report, Drug Control: Actions Needed to Ensure Usefulness of Data on Suspicious Opioid Orders, wa... Read More